Dr. Albert Kheradpour
Claim this profileLoma Linda University Medical Center
Expert in Tumors
Expert in Brain Tumor
54 reported clinical trials
104 drugs studied
About Albert Kheradpour
Education:
- Earned an MD from George Washington University School of Medicine & Health Sciences in 1980.
Experience:
- Possesses over 43 years of experience in the medical field.
- Board-certified in Pediatrics and Pediatric Hematology-Oncology.
- Currently serves as Head of the Pediatrics, Hematology/Oncology Division at Loma Linda University Medical Center.
- Holds the position of Associate Professor in the Pediatrics, Hematology/Oncology Division at Loma Linda University Medical Center.
- Active Investigator at the LLU Cancer Center Biospecimen Laboratory (September 2023 – September 2024).
- Affiliated with Loma Linda University Children's Hospital.
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Brain Tumor
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Albert Kheradpour is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Albert Kheradpour
Clinical Trial Related7 years of experience running clinical trials · Led 54 trials as a Principal Investigator · 24 Active Clinical TrialsTreatments Albert Kheradpour has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Doxorubicin Hydrochloride
- Nivolumab
- Vincristine Sulfate
Breakdown of trials Albert Kheradpour has run
Tumors
Brain Tumor
Lymphoma
Germ Cell Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Albert Kheradpour specialize in?
Albert Kheradpour focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Albert Kheradpour currently recruiting for clinical trials?
Yes, Albert Kheradpour is currently recruiting for 21 clinical trials in Loma Linda California. If you're interested in participating, you should apply.
Are there any treatments that Albert Kheradpour has studied deeply?
Yes, Albert Kheradpour has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Albert Kheradpour?
Apply for one of the trials that Albert Kheradpour is conducting.
What is the office address of Albert Kheradpour?
The office of Albert Kheradpour is located at: Loma Linda University Medical Center, Loma Linda, California 92354 United States. This is the address for their practice at the Loma Linda University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.